NCT06184646 Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women
| NCT ID | NCT06184646 |
| Status | Recruiting |
| Phase | — |
| Sponsor | San Diego State University |
| Condition | Bone Disease, Metabolic |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-03-15 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-03-15 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to examine if calcium and vitamin D supplements and/or prune can prevent bone loss in postmenopausal women.
Eligibility Criteria
Inclusion Criteria: * Postmenopausal * BMD t-score is between 0.5 and 2 SD below the mean * Not on hormone replacement therapy (HRT) and/or other pharmacological agents known to affect bone for at least three months prior to initiation of the study Exclusion Criteria: * Women whose BMD t-score at any site falls below 2.5 SD of the mean * Subjects receiving endocrine (e.g., prednisone, other glucocorticoids) or neuroactive (e.g., dilantin, phenobarbital) drugs or any drugs known to influence bone and calcium metabolism * Subjects who smoke cigarettes or vape * Regular consumption of dried plum or prune juice
Contact & Investigator
Shirin Hooshmand, PhD
PRINCIPAL INVESTIGATOR
San Diego State University
Frequently Asked Questions
Who can join the NCT06184646 clinical trial?
This trial is open to female participants only, studying Bone Disease, Metabolic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06184646 currently recruiting?
Yes, NCT06184646 is actively recruiting participants. Contact the research team at shooshmand@sdsu.edu for enrollment information.
Where is the NCT06184646 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT06184646 clinical trial?
NCT06184646 is sponsored by San Diego State University. The principal investigator is Shirin Hooshmand, PhD at San Diego State University. The trial plans to enroll 200 participants.